TP53 and skin squamous cell carcinoma: In BCC, loss of PTCH1 receptor function results in activation of the G protein-coupled receptor SMO and constitutive activation of the Hedgehog signaling pathway, whereas in cSCC, mutation and inactivation of p53 is an important early pathogenic event [1].